(April 15, 2014) -- Akorn Enterprises, Inc., and Hi-Tech Pharmacal, Inc., will sell the rights and assets to three generic prescription eye medication and two general topical anesthetics to Watson Laboratories, Inc., to settle FTC charges that Akorn’s acquisition of Hi-Tech would be anticompetitive....